Latest Recursion News & Updates

See the latest news and media coverage for Recursion. We track all announcements, press releases, and industry mentions in real time, all in one place.

Recursion

AI-driven drug discovery company

recursion.com

Headquarters: Salt Lake City, United States
Founded year: 2013
Company type: Public company
Number of employees: 700–1,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Recursion

In short: Recursion expanded its AI-driven drug discovery platform, advanced key clinical trials, and pursued a strategic merger with Exscientia.

Company announcements

April 29 Recursion

Recursion to report Q1 2026 results on May 6

Company will host earnings call at 8:00 am ET with webcast and public Q&A.

February 25 Recursion

Recursion reports fourth quarter and full year 2025 financial results

The company achieved key milestones including clinical validation in FAP and a fifth milestone with Sanofi, with $754M cash on hand.

February 5 Recursion

Recursion integrates data layers to advance end-to-end drug discovery

The company's platform combines phenomics, transcriptomics, and patient data via foundation models for novel drug development.

5 November 2025 Recursion

Recursion founder Chris passes CEO role to Najat Khan

Gibson transitions to Board Chair, focusing on research and leadership development, effective January 1.

Media coverage

July 13 Yahoo Finance

Why Recursion Pharmaceuticals (RXRX) Outpaced the Stock Market Today

In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $3.34, indicating a +1.21% shift from the previous trading day.

June 29 Stock Titan

RXRX insider sale notice: 100,000 Class A shares | RXRX SEC Filing - Form 144

Recursion Pharmaceuticals, Inc.

June 29 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Is Up 8.0% After Russell Index Additions Expand Its Investor Base – Has The Bull Case Changed?

In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including the Russell 2000 Value Index, expanding its presence...

June 13 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Stock Valuation After AI Drug Discovery And REC-1245 REC-4881 Updates

Recursion Pharmaceuticals (RXRX) is back in focus as investors weigh fresh updates on its AI-driven drug discovery platform, along with progress in key clinical assets...

Never miss news about Recursion

Track Recursion and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Recursion competitors & trending companies

Browse news for competitors to Recursion and other trending companies.